The Universal Selection Source: Plastics & Elastomers

Industry News

Solutia to sell non-plastics assets to UCB for $500 million

SpecialChem / Dec 3, 2002
ST. LOUIS, Dec. 3 -- Solutia Inc. has agreed to sell several non-plastics assets involving resins, additives, and adhesives, to Brussels-based UCB S.A. for $500 million. The deal will not affect Solutia's performance film and intergrated nylon businesses, a Solutia spokeswoman said.

UCB has made an upfront payment of $10 million for a short period of exclusivity. The transaction, which is expected to close in early 2003, requires regulatory approval. UCB is a pharmaceutical and specialty chemical company which employs 10,000.

The deal strengthens Solutia's balance sheet and allows it to pay down a substantial amount of debt, according to John Hunter, chairman, president, and chief executive officer of Solutia. The divestiture is also part of Solutia's strategy to focus on performance films, specialty products, and nylon.

The agreement includes 10 production sites that make liquid and powder coatings, technical resins, additive products, and pressure-sensitive adhesives. The resins, additives, and adhesives businesses employ approximately 1700 in 22 countries and have sales of over $400 million for the nine months ended Sept. 30.

Solutia will sell manufacturing facilities in Wiesbaden, Frankfurt-Fechenheim, and Hamburg, Germany; Werndorf, Austria; Romano d'Ezzelino, Italy; Dijon, France; Soborg, Denmark; La Llagosta, Spain; Rayong, Thailand; and Suzano, Brazil, as well as research and development facilities in Graz, Austria, and Springfield, MA.


Online Course

15 Days left to register

Thursday Jun 11 2015

By Rob Veraart

Uncover best compliance strategies for EU food contact approval! Regulation Experts, Rachida S. & Rob V. will share their strong practical experience to help you save on migration tests and better manage your Declaration of Compliance & liability issues.

308 Read More
PolyOne webinar on sustainable automotive lightweighting
Channel Alerts

Receive weekly digests on hot topics

Receive your alerts

Back to Top